Using Protide News Today : Breaking News, Live Updates & Top Stories | Vimarsana

NuCana plc: NuCana Announces Five Poster Presentations at the American Association for Cancer Research (AACR) Annual Meeting 2021
NUC-3373 Promotes Natural Killer Cell Activation by Colorectal Cancer Cells
NUC-7738 Demonstrates Anti-Cancer Activity, Prolonged Stable Disease and a Favorable Tolerability Profile in Patients with Advanced Solid Tumors
NUC-7738 Generates High and Prolonged Intracellular Levels of the Active Anti-Cancer Metabolite 3 -dATP
Acelarin Induces Persistent DNA Damage in Biliary Tract Cancer Cells
EDINBURGH, United Kingdom, April 10, 2021 (GLOBE NEWSWIRE) NuCana plc (NASDAQ: NCNA) announced the presentation of five posters at the American Association for Cancer Research (AACR) Annual Meeting 2021 being held virtually April 9 to 14, 2021. Data from all three of NuCana s ProTides in clinical development were presented. Summaries of the posters are described below. ....

United States , United Kingdom , City Of , Hughs Griffith , Marion Janic , Nucana Protides , Chris Brinzey , Company Annual Report On Form , Exchange Commission , American Association For Cancer Research , Encouraging Efficacy Signals , Favorable Safety Profile , Advanced Colorectal , Natural Killer Cell Activation , Colorectal Cancer , Anti Cancer Activity , Prolonged Stable Disease , Favorable Tolerability Profile , Advanced Solid , Prolonged Intracellular Levels , Active Anti Cancer Metabolite , Biliary Tract Cancer , American Association , Cancer Research , Annual Meeting , Using Protide ,